This session will focus on the integrated and continuous biomanufacturing process applied in the production of large molecules with experience shared by Sanofi, Pfizer and BI. Several areas will be discussed including leveraging the at-scale data to support comparability studies, as well as prePPQ campaigns, and lifecycle process validation considerations.
You must be logged in and own this session in order to post comments.